Abstract:Background: Colorectal cancer usually gives rise to a specific anti-tumor immune response, but for unknown reasons the resulting immunity is not able to clear the tumor. Recruitment of activated effector lymphocytes to the tumor is important for efficient anti-tumor responses, while the presence of regulatory T cells (Treg) down-modulate tumor-specific immunity. We therefore aimed to determine homing mechanisms and activation stage of Treg and effector T cell infiltrating colon tumors compared to cells from the unaffected mucosa in patients suffering from colon adenocarcinoma. Methodology/principal findings: Lymphocytes were isolated from unaffected and tumor mucosa from patients with colon adenocarcinoma, and flow cytometry, immunohistochemistry, and quantitative PCR was used to investigate the homing mechanisms and activation stage of infiltrating Treg and conventional lymphocytes. We detected significantly higher frequencies of CD25(high)FOXP3⁺CD127(low) putative Treg in tumors than unaffected mucosa, which had a complete demethylation in the FOXP3 promotor. Tumor-associated Treg had a high expression of CTLA-4, and some appeared to be antigen experienced effector/memory cells based on their expression of αEβ7 (CD103). There were also significantly fewer activated T cells and more CTLA-4⁺ conventional T cells susceptible to immune regulation in the tumor-associated mucosa. In contrast, CD8⁺granzyme B⁺ putative cytotoxic cells were efficiently recruited to the tumors. The frequencies of cells expressing α4β7 and the Th1 associated chemokine receptor CXCR3 were significantly decreased among CD4⁺ T cells in the tumor, while frequencies of CD4⁺CCR4⁺ lymphocytes were significantly increased. Conclusions/significance: This study shows that CCR4⁺CTLA4(hi) Treg accumulate in colon tumors, while the frequencies of activated conventional Th1 type T cells are decreased. The altered lymphocyte composition in colon tumors will probably diminish the ability of the immune system to effectively attack tumor cells, and reducing the Treg activity is an important challenge for future immunotherapy protocols.

[Regulation of Immune Suppressive Cytokines by TLR4 Activation in Colon Cancer Cells].

TLR4 Signaling Promotes Immune Escape of Human Lung Cancer Cells by Inducing Immunosuppressive Cytokines and Apoptosis Resistance.

Pancreatic Cancer Derived Exosomes Regulate the Expression of TLR4 in Dendritic Cells Via Mir-203

TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155

The Role of Toll-Like Receptors (tlrs) in Pan-Cancer

Alteration of Cxcr7 Expression Mediated by Tlr4 Promotes Tumor Cell Proliferation and Migration in Human Colorectal Carcinoma

Mechanism of the Immune Suppression Mediated by Regulatory T Cells in the Microenvironment of Gastric Cancer

Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer

TLR4 regulates RORγt+ regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila

TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells.

The Role of Toll-Like Receptor in Inflammation and Tumor Immunity

Regulatory T, B cells and inflammation: Do they play an important role in lung cancer?

The Regulation of Toll-Like Receptor 2 by Mir-143 Suppresses the Invasion and Migration of a Subset of Human Colorectal Carcinoma Cells

Intratumoral FoxP3+Helios+ Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer

Accumulation Of Foxp3(+) T Regulatory Cells In Draining Lymph Nodes Correlates With Disease Progression And Immune Suppression In Colorectal Cancer Patients

Experimental Therapy for Colon Cancer: Anti-Cancer Effects of TLR9 Agonism, Combination with Other Therapeutic Modalities, and Dependence Upon P53.

The expression of Th17/Treg cells and related cytokines in colon cancer and its relationship with clinical stage

Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis

Comprehensive Bioinformatics Analysis of Toll-Like Receptors (TLRs) in Pan-Cancer

In situ analysis of FOXP3+ regulatory T cells and myeloid dendritic cells in human colorectal cancer tissue and tumor-draining lymph node.

Accumulation of CCR4⁺CTLA-4 FOXP3⁺CD25(hi) regulatory T cells in colon adenocarcinomas correlate to reduced activation of conventional T cells